Table II.
Number (×103) of Type 1 Cytokine-producing CD4+ and CD8+ T Cells in Lung after B. dermatitidis Infection as Measured by Intracellular Cytokine Staining
| IFN-γ
|
TNF-α
|
GM-CSF
|
||||
|---|---|---|---|---|---|---|
| Day | CD4+ | CD8+ | CD4+ | CD8+ | CD4+ | CD8+ |
| Unvaccinated | ||||||
| 0 | 5 ± 2 | 4 ± 2 | 13 ± 8 | 17 ± 9 | 4 ± 2 | 0 ± 0 |
| 2 | 1 ± 0 | 2 ± 1 | 2 ± 1 | 5 ± 2 | 2 ± 1 | 2 ± 1 |
| 4 | 14 ± 4 | 13 ± 4 | 70 ± 33 | 79 ± 31 | 20 ± 8 | 3 ± 1 |
| 6 | 94 ± 44 | 183 ± 118 | 263 ± 147 | 383 ± 214 | 127 ± 57 | 40 ± 16 |
| 8 | 186 ± 99 | 299 ± 166 | 508 ± 342 | 879 ± 64 | 172 ± 91 | 33 ± 16 |
| 12 | 279 ± 105 | 424 ± 161 | 1,438 ± 578 | 2,108 ± 857 | 212 ± 83 | 246 ± 82 |
| Vaccinated | ||||||
| 0 | 23 ± 14 | 10 ± 6 | 64 ± 48 | 40 ± 30 | 31 ± 20 | 1 ± 1 |
| 2a | 92 ± 88 | 36 ± 30 | 178 ± 197 | 87 ± 88 | 87 ± 80 | 16 ± 13 |
| 4b | 325 ± 257 | 226 ± 192 | 1,355 ± 981 | 954 ± 743 | 593 ± 426 | 187 ± 164 |
| 6 | 294 ± 126 | 111 ± 61 | 1,821 ± 855 | 498 ± 301 | 508 ± 265 | 24 ± 14 |
| 8 | 315 ± 121 | 60 ± 33 | 2,510 ± 953 | 291 ± 157 | 920 ± 350 | 13 ± 7 |
| 12 | 225 ± 105 | 64 ± 38 | 1,890 ± 868 | 388 ± 196 | 605 ± 331 | 25 ± 13 |
| Vaccinated/CD4− c | ||||||
| 0 | 3 ± 1 | 7 ± 4 | 2 ± 1 | |||
| 2 a | 22 ± 12 | 102 ± 97 | 21 ± 12 | |||
| 4 b | 501 ± 141 | 1,779 ± 86 | 312 ± 107 | |||
| 6 | 334 ± 133 | 1,009 ± 673 | 248 ± 104 | |||
| 8 | 206 ± 62 | 1,015 ± 422 | 172 ± 53 | |||
| 12 | 201 ± 119 | 1,234 ± 758 | 263 ± 162 | |||
Data represent an average of four independent experiments (lungs of 6–12 mice per group were pooled at each time point). Mice were infected with 2 × 103 yeast and analyzed serially after infection.
P ≤ 0.01 vs. unvaccinated mice for all three cytokines.
P ≤ 0.005 vs. unvaccinated mice for all three cytokines.
C57BL/6 mice were depleted of CD4+ T cells during the induction and expression phase of vaccine immunity.